Treatment of graft-versus-host disease with mesenchymal cells as a complication of a liver transplantation
-
1
Clínica Universitaria de Navarra
info
-
2
Instituto de Investigación Sanitaria de Navarra
info
Instituto de Investigación Sanitaria de Navarra
Pamplona, España
-
3
Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas
info
Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas
Madrid, España
ISSN: 1130-0108
Argitalpen urtea: 2018
Alea: 110
Zenbakia: 11
Orrialdeak: 734 - 736
Mota: Artikulua
Beste argitalpen batzuk: Revista Española de Enfermedades Digestivas
Laburpena
We present the case of a liver transplant (LT) recipient donor who developed graft versus host disease (GVHD).The main features were cutaneous rash, diarrhea and pancytopenia. Mesenchymal cells were administered as part of the treatment. This is the first case of a patient with GVHD after LT reported to date. Despite the treatment, there was no improvement in aplasia or gastrointestinal symptoms and the patient died due to a disseminated infection.
Erreferentzia bibliografikoak
- 10.3748/wjg.14.974
- 10.1111/ctr.12627
- 10.1097/TP.0000000000001406
- 4 Pérez-Saborido B, Asensio-Díaz E, Barrera-Rebollo A et al. Graft versus host disease as a complication after liver transplantation: A rare but serious association. Rev Esp Enferm Dig. 2016 Jan;108(1):49-50.
- 10.1016/j.transproceed.2012.05.036
- 10.1097/TXD.0000000000000691
- 10.1016/j.bbmt.2014.06.015
- 10.1371/journal.pone.0136991